Evaluation of epidermal growth factor receptor (EGFR) as a prognostic factor for survival in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy as first-line treatment
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. Janas, L. R. Bailey, K. Schmidt, N. Bindslev, M. Wolf, A. Fandi, J. Askaa, R. Herbst, G. Giaccone, D. H. Johnson
Institutions: Vanderbilt University, Vanderbilt University Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2344144556